Becker Capital Management Inc
Source: SEC Form 13F · as of Mar 2026Becker Capital Management Inc holds 19 biotech & pharma companies tracked by BioSniper, totaling $308.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$308.0M
| Company | Shares | Value |
|---|---|---|
| MCKMcKesson Corporation | 73,184 | $63.4M |
| JNJJOHNSON & JOHNSON | 247,678 | $60.5M |
| AZNASTRAZENECA PLC | 176,914 | $34.9M |
| MRKMerck & Co., Inc. | 271,104 | $32.8M |
| AMGNAMGEN INC | 85,675 | $30.1M |
| SNYSanofi | 496,394 | $23.9M |
| LLYELI LILLY & Co | 23,766 | $21.9M |
| PFEPFIZER INC | 490,446 | $13.8M |
| DGXQuest Diagnostics Incorporated | 62,849 | $12.3M |
| BAXBaxter International Inc. | 271,603 | $4.6M |
| ABBVAbbVie Inc. | 14,799 | $3.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 7,033 | $1.9M |
| NVSNovartis AG | 9,357 | $1.4M |
| ABTABBOTT LABORATORIES | 9,871 | $1.0M |
| GILDGILEAD SCIENCES, INC. | 6,060 | $845K |
| PMPhilip Morris International Inc | 3,058 | $510K |
| BMYBRISTOL MYERS SQUIBB CO | 8,252 | $500K |
| ZTSZoetis Inc. | 3,156 | $373K |
| TRIBTRINITY BIOTECH PLC | 18,000 | $10K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.